Address/ Địa chỉ: RM 639, Bldg 220 (Bio-Engineerng Research Bldg), 1 Gwanak-ro, Gwanak-gu, Seoul, 08826, Republic of Korea

Website: www.kanzen.co.kr / www.snowtox.co.kr

Company introduction:

Kanzen is a top-tier global bio & anti-aging enterprise dedicated to revolutionizing transdermal drug delivery and next-generation skincare by combining cutting-edge science with advanced beauty solutions.

Core Technology & Patent Highlights
• Patented CDP Platform (Cargo Delivery Peptide): A proprietary, big data-engineered peptide delivery technology offering over 10 times higher skin and cell permeability compared to conventional Cell-Penetrating Peptides (CPP).
• Proprietary Bio-Source Assets: Independently discovered and developed core biological assets, including 7 proprietary Botulinum strains, Hyaluronic Acid (HA) producing strains, and functional cosmetic raw materials, securing fundamental biotechnology competitiveness.
• 300 Trillion KRW Market Scalability: A versatile global platform technology solving active ingredient delivery challenges across topical/sustained-release botulinum therapeutics, cosmeceuticals, hair care, anti-obesity drugs, oncology, CNS therapeutics, gene therapies, and vaccines.

Key R&D Pipelines
1. Topical Botulinum Toxin Therapeutics
2. Sustained-Release Botulinum Toxins
3. Pharmaceutical Botulinum Toxin Injectables
4. Next-Generation Cosmeceuticals

Company product: Snowtox Crystal Treatment Serum (30ml)